Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | President | March 17, 2026 | March 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date March 17, 2026 · Filed March 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,000 |
Ending reported balance
After 2026-03-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-17 · Exercise / conversion · Acquired 31,707 · Balance 46,707 Row 2 · 2026-03-17 · Sale · Disposed 31,707 · Balance 15,000 F1: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $451.36 to $460.288. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $138.87 · Expires 2027-08-15 | Direct | 0 |
Reported balance
After 2026-03-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-17 · Exercise / conversion · Disposed 31,707 · Balance 0 F2: The option vested in full on February 15, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $451.36 to $460.288. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F2: The option vested in full on February 15, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 17, 2026 Filed Mar 19, 2026 20:45 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 31,707 | $0.00 Strike: $138.87 | $0.00 |
DisclosureSEC source: 0001677399-26-000002 · wk-form4_1773953138.xml · derivative · entry 3 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,707 shares Expires 2027-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in full on February 15, 2026. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 20:45 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 31,707 | $455.30 | $14,436,197.10 |
DisclosureSEC source: 0001677399-26-000002 · wk-form4_1773953138.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $451.36 to $460.288. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 20:45 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 31,707 | $138.87 | $4,403,151.09 |
DisclosureSEC source: 0001677399-26-000002 · wk-form4_1773953138.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 21:38 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 21,503 | $595.66 | $12,808,476.98 |
DisclosureSEC source: 0001677399-25-000006 · wk-form4_1762551536.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,000 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 6, 2025. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $588.64 to $599.86. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| October 29, 2025 Filed Oct 29, 2025 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,568 | $0.00 Strike: $166.73 | $0.00 |
DisclosureSEC source: 0001677399-25-000004 · wk-form4_1761772348.xml · derivative · entry 6 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,568 shares Expires 2026-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in full on October 27, 2025. Read SEC document |
| October 29, 2025 Filed Oct 29, 2025 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,568 | $585.00 | $2,087,280.00 |
DisclosureSEC source: 0001677399-25-000004 · wk-form4_1761772348.xml · nonDerivative · entry 4 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,503 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| October 29, 2025 Filed Oct 29, 2025 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,568 | $166.73 | $594,892.64 |
DisclosureSEC source: 0001677399-25-000004 · wk-form4_1761772348.xml · nonDerivative · entry 3 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2025 Filed Oct 29, 2025 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 19,460 | $0.00 Strike: $166.73 | $0.00 |
DisclosureSEC source: 0001677399-25-000004 · wk-form4_1761772348.xml · derivative · entry 5 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,568 Underlying: Common Stock · 19,460 shares Expires 2026-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in full on October 27, 2025. Read SEC document |
| October 27, 2025 Filed Oct 29, 2025 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 19,460 | $605.12 | $11,775,635.20 |
DisclosureSEC source: 0001677399-25-000004 · wk-form4_1761772348.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,503 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $600.00 to $610.66. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| October 27, 2025 Filed Oct 29, 2025 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 19,460 | $166.73 | $3,244,565.80 |
DisclosureSEC source: 0001677399-25-000004 · wk-form4_1761772348.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 21:37 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 41,801 | $0.00 Strike: $107.93 | $0.00 |
DisclosureSEC source: 0001668397-25-000095 · wk-form4_1753738637.xml · derivative · entry 3 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,801 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in full on February 28, 2020. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 21:37 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 41,801 | $453.11 | $18,940,451.11 |
DisclosureSEC source: 0001668397-25-000095 · wk-form4_1753738637.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,503 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $450.039 to $457.992. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 21:37 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 41,801 | $107.93 | $4,511,581.93 |
DisclosureSEC source: 0001668397-25-000095 · wk-form4_1753738637.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 9,886 | $0.00 Strike: $325.73 | $0.00 |
DisclosureSEC source: 0001668397-25-000029 · wk-form4_1741641840.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,886 Underlying: Common Stock · 9,886 shares Expires 2032-03-06 F1 · derivative.exercise_date: The option vests on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 21:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $32.05 | $0.00 |
DisclosureSEC source: 0001668397-24-000178 · wk-form4_1733865891.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2025-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested on February 28, 2022. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 21:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 15,000 | $32.05 | $480,750.00 |
DisclosureSEC source: 0001668397-24-000178 · wk-form4_1733865891.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001668397-24-000151 · wk-form4_1723062024.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. F2 · derivative.expiration_date: The restricted stock units vest in full on the fifth anniversary of the grant date or August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:42 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 17,679 | $0.00 Strike: $90.65 | $0.00 |
DisclosureSEC source: 0001668397-24-000051 · wk-form4_1709761336.xml · derivative · entry 5 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,679 shares Expires 2024-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in full on August 5, 2019. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:42 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 17,679 | $90.65 | $1,602,601.35 |
DisclosureSEC source: 0001668397-24-000051 · wk-form4_1709761336.xml · nonDerivative · entry 3 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:42 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 22,321 | $0.00 Strike: $90.65 | $0.00 |
DisclosureSEC source: 0001668397-24-000051 · wk-form4_1709761336.xml · derivative · entry 4 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,679 Underlying: Common Stock · 22,321 shares Expires 2024-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in full on August 5, 2019. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:42 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 22,321 | $403.03 | $8,996,032.63 |
DisclosureSEC source: 0001668397-24-000051 · wk-form4_1709761336.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,824 F1 · kind: The transactions reported on this line of this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $401.60 to $404.525. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:42 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 22,321 | $90.65 | $2,023,398.65 |
DisclosureSEC source: 0001668397-24-000051 · wk-form4_1709761336.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 21:25 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 2,558 | $393.51 | $1,006,585.79 |
DisclosureSEC source: 0001668397-24-000039 · wk-form4_1709328306.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,824 F1 · shares: Represents shares sold to satisfy tax withholding obligations upon the vesting of restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 21:47 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantRestricted Stock Unit · Derivative | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-23-003514 · doc1.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. F2 · derivative.expiration_date: The restricted stock units vest in full on the fourth anniversary of the grant date or February 17, 2027, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,000 | $0.00 Strike: $28.32 | $0.00 |
DisclosureSEC source: 0001567619-22-020558 · doc1.xml · derivative · entry 3 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2024-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each option vested on March 15, 2021. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,000 | $230.00 | $1,610,000.00 |
DisclosureSEC source: 0001567619-22-020558 · doc1.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| November 15, 2022 Filed Nov 17, 2022 21:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 7,000 | $28.32 | $198,240.00 |
DisclosureSEC source: 0001567619-22-020558 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 31,707 | $0.00 Strike: $138.87 | $0.00 |
DisclosureSEC source: 0001567619-22-004862 · doc1.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,707 Underlying: Common Stock · 31,707 shares Expires 2027-08-15 F1 · derivative.exercise_date: The option vests on the fourth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 20:13 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $28.32 | $0.00 |
DisclosureSEC source: 0001567619-21-018874 · doc1.xml · derivative · entry 3 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 10,000 shares Expires 2024-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each option vested on March 15, 2021. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 20:13 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 10,000 | $211.36 | $2,113,600.00 |
DisclosureSEC source: 0001567619-21-018874 · doc1.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $204.53 to $214.51. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 20:13 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 10,000 | $28.32 | $283,200.00 |
DisclosureSEC source: 0001567619-21-018874 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| April 27, 2021 Filed Apr 29, 2021 20:08 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 23,028 | $0.00 Strike: $166.73 | $0.00 |
DisclosureSEC source: 0001567619-21-008748 · doc1.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,028 Underlying: Common Stock · 23,028 shares Expires 2026-10-27 F1 · derivative.exercise_date: The Option vests on October 27, 2025, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 23:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $28.32 | $0.00 |
DisclosureSEC source: 0000899243-21-016132 · doc4.xml · derivative · entry 3 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 3,000 shares Expires 2024-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each option vested on March 15, 2021. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 23:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,000 | $180.00 | $540,000.00 |
DisclosureSEC source: 0000899243-21-016132 · doc4.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| April 14, 2021 Filed Apr 16, 2021 23:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,000 | $28.32 | $84,960.00 |
DisclosureSEC source: 0000899243-21-016132 · doc4.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 21:32 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0001567619-21-003082 · doc1.xml · derivative · entry 3 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2023-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each option vested on August 10, 2020. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 21:32 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 4,000 | $160.00 | $640,000.00 |
DisclosureSEC source: 0001567619-21-003082 · doc1.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 21:32 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 4,000 | $23.00 | $92,000.00 |
DisclosureSEC source: 0001567619-21-003082 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,200 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0001567619-20-021199 · doc1.xml · derivative · entry 3 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,200 shares Expires 2023-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each option vested on August 10, 2020. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 4,200 | $142.00 | $596,400.00 |
DisclosureSEC source: 0001567619-20-021199 · doc1.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 21:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 4,200 | $23.00 | $96,600.00 |
DisclosureSEC source: 0001567619-20-021199 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:07 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,110 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0001567619-20-016319 · doc1.xml · derivative · entry 6 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,200 Underlying: Common Stock · 3,110 shares Expires 2023-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each option vested on August 10, 2020. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:07 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,110 | $130.00 | $404,300.00 |
DisclosureSEC source: 0001567619-20-016319 · doc1.xml · nonDerivative · entry 4 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 20:07 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,110 | $23.00 | $71,530.00 |
DisclosureSEC source: 0001567619-20-016319 · doc1.xml · nonDerivative · entry 3 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 20:07 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,700 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0001567619-20-016319 · doc1.xml · derivative · entry 5 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,310 Underlying: Common Stock · 3,700 shares Expires 2023-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each option vested on August 10, 2020. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 20:07 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,700 | $130.00 | $481,000.00 |
DisclosureSEC source: 0001567619-20-016319 · doc1.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 20:07 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,700 | $23.00 | $85,100.00 |
DisclosureSEC source: 0001567619-20-016319 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:06 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0001567619-20-015751 · doc1.xml · derivative · entry 3 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,010 Underlying: Common Stock · 3,500 shares Expires 2023-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each option vested on August 10, 2020. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:06 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 3,500 | $128.00 | $448,000.00 |
DisclosureSEC source: 0001567619-20-015751 · doc1.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:06 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,500 | $23.00 | $80,500.00 |
DisclosureSEC source: 0001567619-20-015751 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.